Maternal vaccination against H1N1 influenza and offspring mortality: Population based cohort study and sibling design

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Jonas, F ^a,b   Peter, Ström ^a   Cecilia, Lundholm ^a   Sven, Cnattingius ^a   Anders, Ekbom ^a   Örtqvist, Åke ^a,c   Nils, Feltelius ^d   Fredrik, Granath ^a   Olof, Stephansson ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM COUNTY COUNCIL   (Sweden)

^d Medical Product Agency   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCOME; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MATERNAL TREATMENT; NEWBORN; NEWBORN MORTALITY; PARITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; SEX DIFFERENCE; SIBLING; SMOKING; STILLBIRTH; SWEDEN;

EID: 84951942798     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h5585     Document Type: Article

References (37)

1. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15.
2. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
3. New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009. Wkly Epidemiol Rec 2009;84:261-4
4. Ludvigsson JF, Zugna D, Cnattingius S, et al. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol 2013;28:579-88.
5. Moro PL, Broder K, Zheteyeva Y, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2011;205:473.e1-9.
6. Huang WT, Chen WC, Teng HJ, et al. Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women-Taiwan, November 2009-August 2010. PLoS One 2011;6:e23049.
7. Fell DB, Sprague AE, Liu N, et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 2012;102:e33-40.
8. Pasternak B, Svanstrom H, Molgaard-Nielsen D, et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012;308:165-74.
9. Pasternak B, Svanstrom H, Molgaard-Nielsen D, et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 2012;344:e2794.
10. Dodds L, Macdonald N, Scott J, et al. The association between influenza vaccine in pregnancy and adverse neonatal outcomes. J Obstet Gynaecol Can 2012;34:714-20.
11. Heikkinen T, Young J, van Beek E, et al. Safety of MF59-adjuvanted A/ H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012;207:177.e1-8.
12. Lin TH, Lin SY, Lin CH, et al. AdimFlu-S((R)) influenza A (H1N1) vaccine during pregnancy: the Taiwanese Pharmacovigilance Survey. Vaccine 2012;30:2671-5.
13. Tavares F, Nazareth I, Monegal JS, et al. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 2011;29:6358-65.
14. Omon E, Damase-Michel C, Hurault-Delarue C, et al. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine 2011;29:9649-54.
15. Mackenzie IS, MacDonald TM, Shakir S, et al. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol 2012;73:801-1.
16. Oppermann M, Fritzsche J, Weber-Schoendorfer C, et al. A(H1N1) v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012;30:4445-52.
17. Rubinstein F, Micone P, Bonotti A, et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ 2013;346:f393.
18. Richards JL, Hansen C, Bredfeldt C, et al. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis 2013;56:1216-22.
19. Haberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013;368:333-40.
20. Huang WT, Tang FW, Yang SE, et al. Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a populationbased study in Taiwan. Vaccine 2014;32:6463-8.
21. Trotta F, Da Cas R, Spila Alegiani S, et al. Evaluation of safety of A/ H1N1 pandemic vaccination during pregnancy: cohort study. BMJ 2014;348:g3361.
22. Luteijn JM, Brown MJ, Dolk H. Influenza and congenital anomalies: a systematic review and meta-analysis. Hum Reprod 2014;29:809-23.
23. Beau AB, Hurault-Delarue C, Vidal S, et al. Pandemic A/H1N1 influenza vaccination during pregnancy: a comparative study using the EFEMERIS database. Vaccine 2014;32:1254-8.
24. Chambers CD, Johnson D, Xu R, et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine 2013;31:5026-32.
25. Fell D, Platt R, Lanes A, et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 2015;122:17-26.
26. Medical Products Agency. [Benefits and risks of vaccinations with Pandemrix during pregnancy.] 2009. www.lakemedelsverket.se/ Alla-nyheter/NYHETER-2009/Nyttariskvardering-av-vaccination-med-Pandemrix-av-barn-och-gravida/.
27. Persson I, Granath F, Askling J, et al. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med 2014;275:172-90.
28. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659-67.
29. Cnattingius S, Ericson A, Gunnarskog J, et al. A quality study of a medical birth registry. Scand J Soc Med 1990;18:143-8.
30. Cnattingius S, Villamor E, Johansson S, et al. Maternal obesity and risk of preterm delivery. JAMA 2013;309:2362-70.
31. World Health Organization. BMI classification. 2015. apps.who.int/ bmi/index.jsp?introPage=intro-3.html.
32. Kallen B, Olausson P. Vaccination against H1N1 influenza with Pandemrix((R)) during pregnancy and delivery outcome: a Swedish register study. BJOG 2012;119:1583-90.
33. Sammon CJ, Snowball J, McGrogan A, et al. Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD. PLoS One 2012;7:e51734.
34. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359:1555-64.
35. Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014;371:918-31.
36. Van der Maas N, Dijs-Elsinga J, Kemmeren J, et al. Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant's health: cross-sectional linkage study. BJOG 2015; published online 6 Mar.
37. Anell A. The public-private pendulum-patient choice and equity in Sweden. N Engl J Med 2015;372:1-4.